A government-run insurance program that guarantees equitable access to essential medicines, including those developed through AI. Price controls and subsidies ensure affordability, while a centralized formulary prioritizes drugs with proven efficacy and safety. The program implements a rigorous approval process based on unbiased AI analysis and independent expert review.